CO4960657A1 - Composicion farmaceutica - Google Patents
Composicion farmaceuticaInfo
- Publication number
- CO4960657A1 CO4960657A1 CO98047010A CO98047010A CO4960657A1 CO 4960657 A1 CO4960657 A1 CO 4960657A1 CO 98047010 A CO98047010 A CO 98047010A CO 98047010 A CO98047010 A CO 98047010A CO 4960657 A1 CO4960657 A1 CO 4960657A1
- Authority
- CO
- Colombia
- Prior art keywords
- steroid
- pharmaceutical composition
- aza
- solution according
- azaandrost
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 150000003431 steroids Chemical class 0.000 abstract 2
- SBRHNPKYRAIXQX-QXMPCMEYSA-N (3as,3bs,9ar,9bs,11ar)-9a-methyl-11a-(2-oxoethenyl)-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinolin-7-one Chemical compound C([C@@]1(CCC[C@H]1[C@@H]1CC2)C=C=O)C[C@@H]1[C@]1(C)C2NC(=O)C=C1 SBRHNPKYRAIXQX-QXMPCMEYSA-N 0.000 abstract 1
- 150000000520 4-azasteroids Chemical class 0.000 abstract 1
- 150000000636 6-azasteroids Chemical class 0.000 abstract 1
- NJFPVDFQZGPHID-ZDMKNRLGSA-N C(=O)=C1[C@@H]2[C@](CC1)(C)CC[C@H]1[C@H]2CNC2=CC(CC[C@]12C)=O Chemical compound C(=O)=C1[C@@H]2[C@](CC1)(C)CC[C@H]1[C@H]2CNC2=CC(CC[C@]12C)=O NJFPVDFQZGPHID-ZDMKNRLGSA-N 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- -1 fatty acid ester Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Una solución, caracterizada porque comprende una cantidadefectiva terapéuticamente de un esteroide aza activo farmacéuticamente, y un éster de ácido graso de glicerol o propinlenglicol.La solución de conformidad con la reivindicación 1, caracterizado porque el esteroide es un esteroide 4- aza o 6-aza.La solución de conformidad con la reivindicación 2, caracterizado porque el esteroide es una carbonil-4-azaandrost-1-en-3-ona 17-beta-substituida o una carbonil-6-azaandrost-4-en-3-ona 17-beta-substituida. 1Una composición farmacéutica, caracterizada porque comprende la solución de conformidad con cualquier reivindicación previa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9717428.8A GB9717428D0 (en) | 1997-08-19 | 1997-08-19 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4960657A1 true CO4960657A1 (es) | 2000-09-25 |
Family
ID=10817619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98047010A CO4960657A1 (es) | 1997-08-19 | 1998-08-18 | Composicion farmaceutica |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1007010A2 (es) |
| JP (1) | JP2002511101A (es) |
| KR (1) | KR20010014080A (es) |
| CN (1) | CN1263461A (es) |
| AR (1) | AR016629A1 (es) |
| AU (1) | AU9343098A (es) |
| BR (1) | BR9810458A (es) |
| CA (1) | CA2295016A1 (es) |
| CO (1) | CO4960657A1 (es) |
| GB (1) | GB9717428D0 (es) |
| MA (1) | MA26531A1 (es) |
| PE (1) | PE105699A1 (es) |
| TR (1) | TR199903209T2 (es) |
| WO (1) | WO1999008666A2 (es) |
| ZA (1) | ZA987392B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS6633A (is) * | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Samsetningar af fínasteríð töflum |
| KR101152470B1 (ko) | 2003-08-13 | 2012-06-01 | 바이오콘 리미티드 | 치료제용 마이크로-입자 지방산 염 고형 투약 제형 |
| EP1704162A1 (de) * | 2004-01-02 | 2006-09-27 | PharmaCon Forschung und Beratung GmbH | Verfahren zur herstellung von 1,2-ungesätigten azasteroiden |
| WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
| WO2010117873A2 (en) | 2009-04-06 | 2010-10-14 | Banner Pharmacaps, Inc. | Progesterone solutions for increased bioavailability |
| ES2385240B1 (es) | 2010-07-26 | 2013-09-23 | Gp-Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata. |
| US8900631B2 (en) | 2011-04-28 | 2014-12-02 | Health Science Funding, LLC | Dosage form to increase prasterone bioavailability |
| CN103169712B (zh) * | 2011-12-20 | 2017-10-27 | 重庆华邦制药有限公司 | 提高生物利用度的度他雄胺制剂及其制备方法 |
| WO2014002015A1 (en) | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
| EP2949319A1 (en) | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
| KR101679992B1 (ko) | 2015-12-31 | 2016-11-28 | 주식회사 유유제약 | 프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571817A (en) * | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
| DE3607651A1 (de) * | 1986-03-06 | 1987-09-10 | Schering Ag | Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer |
| TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
| US5550134A (en) * | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
-
1997
- 1997-08-19 GB GBGB9717428.8A patent/GB9717428D0/en active Pending
-
1998
- 1998-08-12 MA MA25211A patent/MA26531A1/fr unknown
- 1998-08-14 PE PE1998000735A patent/PE105699A1/es not_active Application Discontinuation
- 1998-08-14 AR ARP980104050A patent/AR016629A1/es unknown
- 1998-08-17 CA CA002295016A patent/CA2295016A1/en not_active Abandoned
- 1998-08-17 AU AU93430/98A patent/AU9343098A/en not_active Abandoned
- 1998-08-17 CN CN98806380A patent/CN1263461A/zh active Pending
- 1998-08-17 ZA ZA9807392A patent/ZA987392B/xx unknown
- 1998-08-17 EP EP98946351A patent/EP1007010A2/en not_active Withdrawn
- 1998-08-17 WO PCT/EP1998/005194 patent/WO1999008666A2/en not_active Application Discontinuation
- 1998-08-17 KR KR19997012116A patent/KR20010014080A/ko not_active Application Discontinuation
- 1998-08-17 JP JP51280899A patent/JP2002511101A/ja active Pending
- 1998-08-17 BR BR9810458-6A patent/BR9810458A/pt not_active Application Discontinuation
- 1998-08-17 TR TR1999/03209T patent/TR199903209T2/xx unknown
- 1998-08-18 CO CO98047010A patent/CO4960657A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999008666A3 (en) | 1999-04-15 |
| KR20010014080A (ko) | 2001-02-26 |
| JP2002511101A (ja) | 2002-04-09 |
| WO1999008666A2 (en) | 1999-02-25 |
| AU9343098A (en) | 1999-03-08 |
| CN1263461A (zh) | 2000-08-16 |
| TR199903209T2 (xx) | 2000-05-22 |
| GB9717428D0 (en) | 1997-10-22 |
| CA2295016A1 (en) | 1999-02-25 |
| AR016629A1 (es) | 2001-07-25 |
| EP1007010A2 (en) | 2000-06-14 |
| ZA987392B (en) | 2000-02-17 |
| BR9810458A (pt) | 2000-09-05 |
| PE105699A1 (es) | 1999-11-25 |
| MA26531A1 (fr) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2176684T3 (es) | Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico. | |
| ATE262925T1 (de) | Verbesserte arzneiverabreichung an schleimhautoberflächen | |
| DE69826644D1 (de) | Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker | |
| TR200100931T2 (tr) | Yeni sürekli salınımlı oral formülasyonlar | |
| HK1024865A1 (en) | Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies | |
| DE69710065D1 (de) | Androsten-derivate | |
| PT1410791E (pt) | Forma galénica apta a ser administrada oralmente compreendendo metformina e um agente promotor da absorção | |
| AR002355A1 (es) | Composiciones y metodos para administracion local de agentes farmaceuticamente activos. | |
| IL120317A0 (en) | Otic antibacterial compositions | |
| CA2289717A1 (en) | Novel therapy for constipation | |
| CO4960657A1 (es) | Composicion farmaceutica | |
| DK1173153T3 (da) | Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler | |
| ATE241363T1 (de) | Ungesättigte fettsäure und steroide enthaltende kombinationspräparate zur behandlung von entzündungen | |
| TR200103039T2 (tr) | Asetilsalisilik asit ve klopidogrel hidrojenosülfat ihtiva eden bir birim formdaki farmasötik kompozisyon. | |
| ATE226084T1 (de) | Wundheilung und behandlung von fibrose | |
| CA2348474A1 (en) | Pharmaceutically active composition and dispensing device | |
| DK1194109T3 (da) | Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf | |
| RU95113437A (ru) | (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью | |
| PT1043974E (pt) | Lipossomas contendo construcoes peptidicas ramificadas para utilizacao contra o virus da imunodeficiencia humana | |
| AR023705A1 (es) | COMPOSICIoN ToPICA QUE COMPRENDE EL GLUCOCORTICOIDE ANTIINFLAMATORIO HIDROCORTISONA Y UN AGENTE ANTIVIRAL ANALOGO DE NUCLEOSIDO ACICLOVIR Y EL USO DE LA MISMA | |
| ES2086518T3 (es) | Compuesto farmaceutico con accion cicatrizante. | |
| RU94025798A (ru) | Гидрофильный терпеноидный бальзам "таежный" | |
| MX9606254A (es) | Composiciones anti-inflamatorias y curativas para heridas y metodos para preparar y utilizar las mismas. | |
| CO5011086A1 (es) | Budesonida sola o en combinacion con acido ursodesoxicolico en la terapia de enfermedades colestasicas del higado |